Showing 1 - 8 results of 8 for search 'Josep M. Grinyo', query time: 0.04s Refine Results
  1. 1
    <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

    <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach by Zeyar Mohammed Ali, Marinda Meertens, Beatriz Fernández, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Edoardo Melilli, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Impact of Small Molecules Immunosuppressants on P-Glycoprotein Activity and T-cell Function

    Impact of Small Molecules Immunosuppressants on P-Glycoprotein Activity and T-cell Function by Inés Llaudó, Linda Cassis, Joan Torras, Oriol Bestard, Marcel·la Franquesa, Josep M. Cruzado, Gema Cerezo, Esther Castaño, Jordi Petriz, Immaculada Herrero-Fresneda, Josep M. Grinyó, Núria Lloberas

    Published 2012-07-01
    Get full text
    Article
  3. 3
    Herramientas para un ajuste de dosis de tacrolimus más personalizado en el seguimiento de los pacientes con transplante renal. Fenotipo metabolizador según polimorfismos genéticos del CYP3A vs. el cociente concentración-dosis

    Herramientas para un ajuste de dosis de tacrolimus más personalizado en el seguimiento de los pacientes con transplante renal. Fenotipo metabolizador según polimorfismos genéticos... by Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Núria Montero, Ana Coloma, Anna Manonellas, Alexandre Favà, Josep M. Cruzado, Joan Torras, Josep M. Grinyó, Núria Lloberas

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio

    Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentr... by Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Alex Favà, Josep M. Cruzado, Joan Torras, Josep M. Grinyó, Nuria Lloberas

    Published 2024-03-01
    Get full text
    Article
  5. 5
    Different Storing and Processing Conditions of Human Lymphocytes do not Alter P-Glycoprotein Rhodamine 123 Efflux.

    Different Storing and Processing Conditions of Human Lymphocytes do not Alter P-Glycoprotein Rhodamine 123 Efflux. by Gemma Chiva-Blanch, Pepita Giménez-Bonafe, Inés Llaudó, Joan Torras, Josep M Cruzado, Jordi Pétriz, Esther Castaño, Marcella Franquesa, Avelina Tortosa, Immaculada Herrero-Fresneda, Inés Rama, Oriol Bestard, Josep M Grinyó, Núria LLoberas

    Published 2009-11-01
    Get full text
    Article
  6. 6
    Guiding the starting dose of the once-daily formulation of tacrolimus in “de novo” adult renal transplant patients: a population approach

    Guiding the starting dose of the once-daily formulation of tacrolimus in “de novo” adult renal transplant patients: a population approach by Beatriz Fernández-Alarcón, Beatriz Fernández-Alarcón, Oscar Nolberger, Oscar Nolberger, Anna Vidal-Alabró, Raul Rigo-Bonnin, Josep M. Grinyó, Edoardo Melilli, Nuria Montero, Anna Manonelles, Ana Coloma, Alex Favà, Sergi Codina, Josep M. Cruzado, Helena Colom, Nuria Lloberas

    Published 2024-09-01
    Get full text
    Article
  7. 7
    The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

    The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations by Pere Fontova, Lisanne N. van Merendonk, Anna Vidal-Alabró, Raül Rigo-Bonnin, Gema Cerezo, Stefaan van Oevelen, Oriol Bestard, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Joan Torras, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas

    Published 2023-05-01
    Get full text
    Article
  8. 8
    Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialPlain-Language Summary

    Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialPlain-Language Summary by Obbo W. Bredewold, MD, Joe Chan, My Svensson, Annette Bruchfeld, Johan W. de Fijter, Hans Furuland, Josep M. Grinyo, Anders Hartmann, Hallvard Holdaas, Olof Hellberg, Alan Jardine, Lars Mjörnstedt, Karin Skov, Knut T. Smerud, Inga Soveri, Søren S. Sørensen, Anton-Jan van Zonneveld, Bengt Fellström

    Published 2023-01-01
    Get full text
    Article

Search Tools: